Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Portal Hypertension
Who would be the right candidate in which TIPS placement would reduce portal hypertension to allow for a previously unattainable procedure?
(Ex: cholecystectomy, orthopedic surgery, etc.)
Related Questions
When would you choose to measure a patient's spleen stiffness?
What is your endoscopic approach to the management of refractory GAVE in persistently anemic patients?
How do you utilize urine sodium and potassium levels and ratios in diuretic optimization in patients with ascites?
What role do you see for albumin infusions in patients with hypoalbuminemia to help assist in volume status, outside of its use in replenishment after a large volume paracentesis or renal dysfunction?
How does a patient who is PNPLA-3 positive (heterozygote or homozygote) impact how you formulate their therapeutic plan?
How do you utilize Cystatin-C as a marker of renal dysfunction in patients with chronic liver disease?
In what scenario do you continue surveillance of benign liver tumors, e.g., hepatocellular adenoma, in pregnant patients?
What kind of monitoring do you choose in patients at risk for reactivation of hepatitis B who are on immunosuppression?
How do you determine when you would treat an identified spleno-renal shunt and how?
What patient factors guide your selection of maintenance therapies for a patient with auto-immune hepatitis?